
Topical tofacitinib 2% versus tacrolimus 0.1% for pediatric facial atopic dermatitis in skin of colour
SETTING THE SCENE Facial AD in children with skin of

SETTING THE SCENE Facial AD in children with skin of

SETTING THE SCENE The 2% crisaborole formulation is one of

A systematic review and meta-analysis presented at the 2026 ACOG

A large population-based study presented at the 2026 ACOG Scientific

A quality improvement initiative presented at the 2026 ACOG Scientific

Researchers presenting at the 2026 American College of Obstetricians and

Women managing gestational diabetes with a continuous glucose monitor were

New research presented today at the ACOG Annual Clinical and

A sweeping new study presented today at the ACOG Annual

A quality improvement initiative presented Friday at the 2026 ACOG

A retrospective cohort study presented Friday at the 2026 ACOG

Preliminary findings from an ongoing systematic review and meta-analysis presented